The Benefits of DC Therapy for Breast Cancer in Germany: A 2026 Clinical Overview
DC therapy for breast cancer in Germany is a personalized immunotherapy that uses a patient’s own dendritic cells to help the immune system recognize and respond to cancer more effectively. In early‑stage breast cancer, adding DC vaccination to standard therapy has been associated with fewer recurrences. 2026 data showing reductions of up to 30%. It […]
The Benefits of DC Therapy for Breast Cancer in Germany: A 2026 Clinical Overview Read More »









